BridgeMD
New treatment option for Polycystic Ovary Syndrome (PCOS)
Official title Strengthening Healthy Emotional Co-regulation of Mothers With PCOS and Obesity and Their Infants
ClinicalTrials.gov ID: NCT07129434
What this study is testing
- What it's testing
- It is both timely and important to invest in interventions that can improve healthy emotional co-regulation. It is proposed to evaluate the feasibility and limited efficacy of an adapted, brief, multimodal intervention: ECoFam (Emotional connection and Co-regulation for Families).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only
You may be able to join if
- Diagnosis of PCOS
- Obesity according to BMI
- Gave birth at Oulu University Hospital in 2024-25
- PEPPI cohort study participation
- uWECS emotional connection score \<9.0 at pre-test
You likely can't join if
- \- Infant death
The study team makes the final eligibility decision.
Where it's taking place
- Oulu, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oulu, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.